Mojica-Pisciotti Mary Luz, Panovský Roman, Holeček Tomáš, Opatřil Lukáš
International Clinical Research Center at St. Anne's University Hospital, 60200 Brno, Czech Republic.
1st Department of Internal Medicine/Cardioangiology at St. Anne's University Hospital, 60200 Brno, Czech Republic.
Rev Cardiovasc Med. 2022 Oct 21;23(11):355. doi: 10.31083/j.rcm2311355. eCollection 2022 Nov.
On March 11, 2020, the World Health Organization raised the coronavirus disease 2019 (COVID-19) status to a pandemic level. The disease caused a global outbreak with devastating consequences, and a fair percentage of patients who have recovered from it continue experiencing persistent sequelae. Hence, identifying the medium and long-term effects of the COVID-19 disease is crucial for its future management. In particular, cardiac complications, from affected function to myocardial injuries, have been reported in these patients. Considering that cardiovascular magnetic resonance (CMR) imaging is the gold standard in diagnosing myocardial involvement and has more advantages than other medical imaging modalities, assessing the outcomes of patients who recovered from COVID-19 with CMR could prove beneficial. This review compiles common findings in CMR in patients from the general population who recovered from COVID-19. The CMR-based techniques comprised parametric mapping for analyzing myocardial composition, feature tracking for studying regional heart deformation, and late gadolinium enhancement for detecting compromised areas in the cardiac muscle. A total of 19 studies were included. The evidence suggests that it is more likely to find signs of myocardial injury in patients who recovered from COVID-19 than in healthy controls, including changes in T1 and T2 mapping relaxation times, affected strain, or the presence of late gadolinium enhancement (LGE) lesions. However, more than two years after the outbreak, there is still a lack of consensus about how these parameters may indicate cardiac involvement in patients who recovered from the disease, as limited and contradictory data is available.
2020年3月11日,世界卫生组织将2019冠状病毒病(COVID-19)的疫情级别提升至大流行水平。该疾病在全球爆发,造成了毁灭性后果,相当一部分康复患者仍持续存在后遗症。因此,确定COVID-19疾病的中长期影响对其未来管理至关重要。特别是,这些患者已报告出现心脏并发症,从功能受影响到心肌损伤。鉴于心血管磁共振(CMR)成像在诊断心肌受累方面是金标准,且比其他医学成像方式具有更多优势,用CMR评估COVID-19康复患者的病情可能会有帮助。本综述汇总了普通人群中COVID-19康复患者CMR的常见研究结果。基于CMR的技术包括用于分析心肌成分的参数映射、用于研究局部心脏变形的特征追踪以及用于检测心肌受损区域的延迟钆增强。共纳入19项研究。证据表明,与健康对照相比,COVID-19康复患者更有可能出现心肌损伤迹象,包括T1和T2映射弛豫时间的变化、应变受影响或存在延迟钆增强(LGE)病变。然而,在疫情爆发两年多后,对于这些参数如何表明疾病康复患者的心脏受累仍缺乏共识,因为可用数据有限且相互矛盾。